Analyze This: Drugmakers' Earnings; Insight, Outlook For Drugmakers
- 00:03:48
- YouTube
Analyze This: Drugmakers' Earnings; Insight, Outlook For Drugmakers
Merck KGAA profit more than doubled; Lonza profit beats estimates on shift toward drug ingredients; Analysis by Andrew Witty, GlaxoSmithKline CEO; Analysis by Gbola Amusa of UBS; Report and analysis by Ryan Chilcotte of Bloomberg News
YouTube | July 23, 2008
Analyze This: Drugmakers' Earnings; Insight, Outlook For Drugmakers
Batstone-Carr Sees Glaxo 'Threat' From Off-Patent Drugs: Video
WHO declares swine flu pandemic, no change in Canada's approach
Is Avandia the next Vioxx?
U.S. Stocks Rise as Merck, Schering Lead Drugmaker Rally
Stocks to Watch: Energy Companies, Homebuilders, Housing-Related Stocks, Healthcare Companies, Consumer Staples, Financials, JPMorgan's Hold List
Previous Page
Next Page
